IDENTIFICATION OF NOVEL MUTATIONS IN THE CDKN1B GENE IN INVASIVE CARCINOMA OF BREAST

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Protein Structure Modeling Using MODELLER

  2016cited by this paper
• Comparative Protein Structure Modeling Using MODELLER

  2016cited by this paper
• Introduction to proteins—structure, function, and motion

  2012cited by this paper
• DelPhi: a comprehensive suite for DelPhi software and associated resources

  2012cited by this paper
• CPORT: A Consensus Interface Predictor and Its Performance in Prediction-Driven Docking with HADDOCK

  2011cited by this paper
• Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition

  2010cited by this paper
• The HADDOCK web server for data-driven biomolecular docking

  2010cited by this paper
• Protein structure prediction on the Web: a case study using the Phyre server

  2009cited by this paper
• Structural basis of protein kinase C isoform function.

  2008cited by this paper
• QMEAN: A comprehensive scoring function for model quality assessment

  2008cited by this paper
• The Proteomics of N-terminal Methionine Cleavage*S

  2006cited by this paper
• Akt-Dependent T198 Phosphorylation of Cyclin-Dependent Kinase Inhibitor p27kip1 in Breast Cancer

  2004cited by this paper
• PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization

  2002cited by this paper
• p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis

  2001cited by this paper
• p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6

  1997cited by this paper
• p27/Kip1 mutation found in breast cancer.

  1996cited by this paper
• A Cell Cycle Regulator and Cancer

  1996cited by this paper
• Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

  1996cited by this paper
• p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

  1995cited by this paper
• Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma.

  1995cited by this paper
• Deletion of p16 and p15 genes in brain tumors.

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation.

  1990cited by this paper

• No citing papers are available for this paper.